中文 | English
Return
Total: 48 , 1/5
Show Home Prev Next End page: GO
MeSH:(Prostate-Specific Antigen/therapeutic use*)

1.Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial.

Yifan CHANG ; Xianzhi ZHAO ; Yutian XIAO ; Shi YAN ; Weidong XU ; Ye WANG ; Huojun ZHANG ; Shancheng REN

Frontiers of Medicine 2023;17(2):231-239

2.Molecular markers in prostate cancer. Part II: potential roles in management.

Sachin AGRAWAL ; Krishnaji P PATIL ; William D DUNSMUIR

Asian Journal of Andrology 2009;11(1):22-27

3.Lycopene can reduce prostate-specific antigen velocity in a phase II clinical study in Chinese population.

Xin ZHANG ; Yong YANG ; Qi WANG

Chinese Medical Journal 2014;127(11):2143-2146

4.Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial.

Byung Ha CHUNG ; Jian HUANG ; Hiroji UEMURA ; Young Deuk CHOI ; Zhang-Qun YE ; Hiroyoshi SUZUKI ; Taek Won KANG ; Da-Lin HE ; Jae Young JOUNG ; Sabine D BROOKMAN-MAY ; Sharon MCCARTHY ; Amitabha BHAUMIK ; Anildeep SINGH ; Suneel MUNDLE ; Simon CHOWDHURY ; Neeraj AGARWAL ; Ding-Wei YE ; Kim N CHI ; Hirotsugu UEMURA

Asian Journal of Andrology 2023;25(6):653-661

5.PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study.

Xin-Xing DU ; Yan-Hao DONG ; Han-Jing ZHU ; Xiao-Chen FEI ; Yi-Ming GONG ; Bin-Bin XIA ; Fan WU ; Jia-Yi WANG ; Jia-Zhou LIU ; Lian-Cheng FAN ; Yan-Qing WANG ; Liang DONG ; Yin-Jie ZHU ; Jia-Hua PAN ; Bai-Jun DONG ; Wei XUE

Asian Journal of Andrology 2023;25(2):179-183

6.Effects of antibiotic and anti-inflammatory treatment on serum PSA and free PSA levels in patients with chronic prostatitis IIIA.

Wei WANG ; Wei-lie HU ; Huai YANG ; Xiao-fu QIU ; Chang-zheng ZHANG

National Journal of Andrology 2006;12(9):787-790

7.Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial.

Chengyuan GU ; Zengjun WANG ; Tianxin LIN ; Zhiyu LIU ; Weiqing HAN ; Xuhui ZHANG ; Chao LIANG ; Hao LIU ; Yang YU ; Zhenzhou XU ; Shuang LIU ; Jingen WANG ; Linghua JIA ; Xin YAO ; Wenfeng LIAO ; Cheng FU ; Zhaohui TAN ; Guohua HE ; Guoxi ZHU ; Rui FAN ; Wenzeng YANG ; Xin CHEN ; Zhizhong LIU ; Liqiang ZHONG ; Benkang SHI ; Degang DING ; Shubo CHEN ; Junli WEI ; Xudong YAO ; Ming CHEN ; Zhanpeng LU ; Qun XIE ; Zhiquan HU ; Yinhuai WANG ; Hongqian GUO ; Tiwu FAN ; Zhaozhao LIANG ; Peng CHEN ; Wei WANG ; Tao XU ; Chunsheng LI ; Jinchun XING ; Hong LIAO ; Dalin HE ; Zhibin WU ; Jiandi YU ; Zhongwen FENG ; Mengxiang YANG ; Qifeng DOU ; Quan ZENG ; Yuanwei LI ; Xin GOU ; Guangchen ZHOU ; Xiaofeng WANG ; Rujian ZHU ; Zhonghua ZHANG ; Bo ZHANG ; Wanlong TAN ; Xueling QU ; Hongliang SUN ; Tianyi GAN ; Dingwei YE

Chinese Medical Journal 2023;136(10):1207-1215

8.Efficacy of periprostatic nerve block anesthesia for pain control in transrectal ultrasound- guided systematic prostate biopsy.

Yi XIE ; Fang-Jian ZHOU ; Yong-Hong LI ; Li-Juan JIANG ; Zhi-Ming WU ; Zi-Ke QIN ; Hui HAN ; Zhuo-Wei LIU

Journal of Southern Medical University 2016;36(5):701-704

9.Can antibiotic treatment exclude inflammation in the differential diagnosis of elevated PSA?.

Jun LIU ; Wei-Lie HU

National Journal of Andrology 2012;18(8):747-750

10.Predictors of efficacy of corticosteroid switching from abiraterone plus prednisone to dexamethasone in patients with metastatic castration-resistant prostate cancer.

Yu-Chao NI ; Jin-Ge ZHAO ; Meng-Ni ZHANG ; Yi-Jun ZHANG ; Zhen-Yu YANG ; Ni CHEN ; Jun-Ru CHEN ; Peng-Fei SHEN ; Guang-Xi SUN ; Xing-Ming ZHANG ; Yong-Hong LI ; Hao ZENG

Asian Journal of Andrology 2022;24(2):154-160

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 48 , 1/5 Show Home Prev Next End page: GO